Market Cap | 1.08B | P/E | 36.23 | EPS this Y | - | Ern Qtrly Grth | -8.70% |
Income | 30.36M | Forward P/E | 37.79 | EPS next Y | - | 50D Avg Chg | - |
Sales | 147.42M | PEG | - | EPS past 5Y | 13.90% | 200D Avg Chg | 3.00% |
Dividend | 1.00% | Price/Book | 13.85 | EPS next 5Y | 13.00% | 52W High Chg | -8.00% |
Recommedations | 3.00 | Quick Ratio | 0.26 | Shares Outstanding | 23.88M | 52W Low Chg | 32.00% |
Insider Own | 36.75% | ROA | 19.51% | Shares Float | 15.09M | Beta | 0.47 |
Inst Own | 51.70% | ROE | 54.41% | Shares Shorted/Prior | 205.15K/173.25K | Price | 43.84 |
Gross Margin | 62.29% | Profit Margin | 20.60% | Avg. Volume | 33,440 | Target Price | - |
Oper. Margin | 24.81% | Earnings Date | Jul 30 | Volume | 24,952 | Change | 2.29% |
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Amandla MK Trust | 10% Owner 10% Owner | Jan 04 | Sell | 40.71 | 7,214 | 293,682 | 3,831,362 | 01/08/24 |
Hays Michael D. | CEO & President CEO & President | Jan 02 | Option | 18.8 | 2,904 | 54,595 | 2,904 | 01/04/24 |
Amandla MK Trust | 10% Owner 10% Owner | Dec 12 | Sell | 41.56 | 26,263 | 1,091,490 | 4,159,815 | 12/14/23 |
Amandla MK Trust | 10% Owner 10% Owner | Dec 07 | Sell | 41.56 | 54,704 | 2,273,498 | 4,186,078 | 12/11/23 |
Amandla MK Trust | 10% Owner 10% Owner | Dec 04 | Sell | 41.6 | 2,550 | 106,080 | 4,240,782 | 12/06/23 |
Amandla MK Trust | 10% Owner 10% Owner | Nov 15 | Sell | 42.1037 | 403 | 16,968 | 4,244,116 | 11/17/23 |
Amandla MK Trust | 10% Owner 10% Owner | Oct 11 | Sell | 44.9135 | 1,601 | 71,907 | 4,244,519 | 10/13/23 |
Amandla MK Trust | 10% Owner 10% Owner | Jun 23 | Sell | 45.11 | 2,091 | 94,325 | 4,246,120 | 06/27/23 |
Amandla MK Trust | 10% Owner 10% Owner | Jun 20 | Sell | 45 | 19,346 | 870,570 | 4,248,211 | 06/22/23 |
Amandla MK Trust | 10% Owner 10% Owner | Jun 14 | Sell | 45.06 | 33,027 | 1,488,197 | 4,267,557 | 06/16/23 |
Amandla MK Trust | 10% Owner 10% Owner | Jun 12 | Sell | 45.04 | 2,000 | 90,080 | 4,300,584 | 06/14/23 |
Amandla MK Trust | 10% Owner 10% Owner | Jun 08 | Sell | 45.52 | 12,626 | 574,736 | 4,302,584 | 06/12/23 |
Amandla MK Trust | 10% Owner 10% Owner | Jun 05 | Sell | 45.71 | 38,629 | 1,765,732 | 4,315,210 | 06/07/23 |
Amandla MK Trust | 10% Owner 10% Owner | May 31 | Sell | 45.18 | 21,095 | 953,072 | 4,353,839 | 06/02/23 |
Amandla MK Trust | 10% Owner 10% Owner | May 23 | Sell | 45 | 29,000 | 1,305,000 | 4,374,934 | 05/25/23 |
Amandla MK Trust | 10% Owner 10% Owner | Apr 21 | Sell | 45.04 | 1,300 | 58,552 | 4,403,934 | 04/25/23 |
RAASCH JONA S | COO, NRC Health COO, NRC Health | Mar 31 | Sell | 43.76 | 23,931 | 1,047,221 | 1,688 | 04/04/23 |
Amandla MK Trust | 10% Owner 10% Owner | Jan 09 | Sell | 40.7201 | 6,370 | 259,387 | 4,411,639 | 01/11/23 |
Hays Michael D. | CEO & President CEO & President | Jan 03 | Option | 14.50 | 10,938 | 158,601 | 45,040 | 01/05/23 |
Amandla MK Trust | 10% Owner 10% Owner | Oct 25 | Sell | 40.59 | 36,724 | 1,490,627 | 4,480,604 | 10/27/22 |
RAASCH JONA S | COO, NRC Health COO, NRC Health | Sep 29 | Option | 13.17 | 23,581 | 310,562 | 23,581 | 10/03/22 |
Amandla MK Trust | 10% Owner 10% Owner | Sep 14 | Sell | 38.5890 | 100,000 | 3,858,900 | 4,661,639 | 09/16/22 |
Amandla MK Trust | 10% Owner 10% Owner | Apr 21 | Sell | 39.87 | 100 | 3,987 | 5,931,972 | 04/25/22 |
Amandla MK Trust | 10% Owner 10% Owner | Apr 19 | Sell | 39.91 | 3,522 | 140,563 | 5,932,072 | 04/21/22 |
Amandla MK Trust | 10% Owner 10% Owner | Apr 07 | Sell | 40.25 | 2,400 | 96,600 | 5,935,594 | 04/11/22 |